Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer
Stefanie Schmidt, Frank Kunath, Bernadette Coles, Désirée Louise Draeger, Laura‐Maria Krabbe, Rick Dersch, Samuel Kilian, Katrin Jensen, Philipp Dahm, Joerg J Meerpohl
Abstract
Outcome 4 Time to progression.......
Topics & Concepts
MedicineBladder cancerHazard ratioMitomycin CMeta-analysisUrologyCarcinoma in situRandomized controlled trialRelative riskConfidence intervalInternal medicineOncologyCancerSurgeryBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and Treatments